Skip to content
S854Senate2021-2022 SessionSame asA1248

Legalize and Tax Marijuana

Official title

“Enacts the "marihuana regulation and taxation act"; repealer”

Sponsor Liz KruegerSD-28+24 co-sponsorsAffects Finance
Status
Signed by Governor
Impact
10/10
Transformational
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill legalizes, regulates, and taxes cannabis in New York, creating the Office of Cannabis Management and establishing licensing, equity, and safety provisions for adult and medical use.

Why it matters

  1. Equity and Social Justice Are Central. The bill aims not just to legalize cannabis, but to redress the harms of past criminalization. It includes a strong social and economic equity mandate, prioritizing licenses for people from communities disproportionately impacted by drug enforcement, as well as minority-, women-, and veteran-owned businesses, and distressed farmers. The goal is for 50% of licenses to go to these groups, with extra support and an incubator program to help them succeed.

  2. Robust Oversight, Regulation, and Consumer Protections. The legislation creates an independent Office of Cannabis Management (OCM) and a Cannabis Control Board with significant powers. These entities will set standards for licensing, product safety, packaging, advertising, and environmental impact. There are strict controls to prevent sales to minors, limit market domination, and require lab testing of products, aiming to build a tightly regulated, transparent legal market.

  3. Major Changes to Criminal and Civil Law. The bill not only legalizes cannabis but also repeals old laws relating to marijuana offenses, provides protections against discrimination or denial of services (like housing, employment, or child custody) based solely on legal cannabis use, and limits cooperation with federal cannabis enforcement. This is intended to reduce mass incarceration and address collateral consequences of past enforcement.

  4. Dedicated Funding for Community Reinvestment and Public Health. Tax revenues and licensing fees from legal cannabis will fund state grants focused on communities most harmed by criminalization, as well as drug treatment, public education, and public health campaigns about cannabis risks and responsible use. These investments are intended to mitigate negative impacts and support positive social outcomes from legalization.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Legalize and Tax Marijuana

Plain English, a few words. Used as the page title.

Sponsors

History

  1. Signed chap.92
  2. Delivered to governor
  3. Returned to senate
  4. Passed assembly
  5. Ordered to third reading rules cal.46
  6. Substituted for A1248A
  7. Referred to ways and means
  8. Delivered to assembly
  9. Passed senateVote 40–23
  10. Ordered to third reading cal.641
  11. Reported and committed to rules
  12. Print number 854a
Show 2 earlier actions
  1. Amend (t) and recommit to finance
  2. Referred to finance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A1248Assembly

Legalize and Tax Marijuana

Assembly Floor Calendar · Sponsor Crystal Peoples-Stokes

Impact 10 · Transformational0% to pass

Full text

128 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

854--A

2021-2022 Regular Sessions

IN SENATE (Prefiled)

January 6, 2021

Introduced by Sens. KRUEGER, BAILEY, BENJAMIN, BIAGGI, BRESLIN, BRIS- PORT, BROUK, COMRIE, COONEY, GIANARIS, HINCHEY, HOYLMAN, JACKSON, KENNEDY, LIU, MAY, MYRIE, PARKER, RAMOS, RIVERA, SALAZAR, SANDERS, SAVINO, SEPULVEDA, SERRANO -- read twice and ordered printed, and when printed to be committed to the Committee on Finance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT in relation to constituting chapter 7-A of the consolidated laws, in relation to the creation of a new office of cannabis management, as an independent entity within the division of alcoholic beverage control, providing for the licensure of persons… Show all

AN ACT in relation to constituting chapter 7-A of the consolidated laws, in relation to the creation of a new office of cannabis management, as an independent entity within the division of alcoholic beverage control, providing for the licensure of persons authorized to cultivate, process, distribute and sell cannabis and the use of cannabis by persons aged twenty-one or older; to amend the public health law, in relation to the description of cannabis; to amend the penal law, in relation to the growing and use of cannabis by persons twenty-one years of age or older; to amend the tax law, in relation to providing for the levying of taxes on cannabis; to amend the criminal procedure law, the civil practice law and rules, the general business law, the state finance law, the executive law, the penal law, the alcoholic beverage control law, the general obligations law, the social services law, the labor law, the family court act, and the vehicle and traffic law, in relation to making conforming changes; to amend the public health law, in relation to the definition of smoking; to amend the state finance law, in relation to establishing the New York state cannabis revenue fund, the New York state drug treatment and public education fund and the New York state community grants reinvestment fund; to amend chapter 90 of the laws of 2014 amending the public health law, the tax law, the state finance law, the general business law, the penal law and the criminal procedure law relating to medical use of marihuana, in relation to the effectiveness thereof; to amend chapter 174 of the laws of 1968 constituting the urban development corporation act, in relation to loans to social and economic equity applicants, providing increased drug recognition awareness and [ ] is old law to be omitted.

S. 854--A 2 Advanced Roadside Impaired Driver Enforcement training, directing a study designed to evaluate methodologies and technologies for the detection of cannabis-impaired driving, providing for the transfer of employees and functions from the department… Show all

S. 854--A 2 Advanced Roadside Impaired Driver Enforcement training, directing a study designed to evaluate methodologies and technologies for the detection of cannabis-impaired driving, providing for the transfer of employees and functions from the department of health to the office of cannabis management; to repeal certain provisions of the public health law relating to growing of cannabis and medical use of marihuana; to repeal article 221 of the penal law relating to offenses involving marihuana; to repeal paragraph (f) of subdivision 2 of section 850 of the general business law relating to drug related paraphernalia; and to repeal certain provisions of the penal law relating to making conforming changes

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. This act shall be known and may be cited as the "marihuana regulation and taxation act".

§ 2. Chapter 7-A of the consolidated laws is enacted, to read as follows:

CHAPTER 7-A OF THE CONSOLIDATED LAWS

CANNABIS LAW

ARTICLE 1

SHORT TITLE; LEGISLATIVE FINDINGS AND INTENT;

DEFINITIONS Section 1. Short title.

2. Legislative findings and intent.

3. Definitions.

Section 1. Short title. This chapter shall be known and may be cited and referred to as the "cannabis law".

§ 2. Legislative findings and intent. The legislature finds that existing marihuana laws have not been beneficial to the welfare of the general public. Existing laws have been ineffective in reducing or curbing marihuana use and have instead resulted in devastating collateral consequences including mass incarceration and other complex generational trauma, that inhibit an otherwise law-abiding citizen's ability to access housing, employment opportunities, and other vital services. Existing laws have also created an illicit market which represents a threat to public health and reduces the ability of the legislature to deter the accessing of marihuana by minors. Existing marihuana laws have disproportionately impacted African-American and Latinx communities.

The intent of this act is to regulate, control, and tax marihuana, heretofore known as cannabis, generate significant new revenue, make substantial investments in communities and people most impacted by cannabis criminalization to address the collateral consequences of such criminalization, prevent access to cannabis by those under the age of twenty-one years, reduce the illegal drug market and reduce violent crime, reduce participation of otherwise law-abiding citizens in the illicit market, end the racially disparate impact of existing cannabis laws, create new industries, protect the environment, improve the state's resiliency to climate change, protect the public health, safety and welfare of the people of the state, increase employment and strengthen New York's agriculture sector.

S. 854--A 3

Nothing in this act is intended to limit the authority of any district, government agency or office or employers to enact and enforce policies pertaining to cannabis in the workplace; to allow driving under the influence of cannabis; to allow individuals to engage in conduct that endangers others; to allow smoking cannabis in any location where smoking tobacco is prohibited; or to require any individual to engage in any conduct that violates federal law or to exempt anyone from any requirement of federal law or pose any obstacle to the federal enforcement of federal law.

The legislature further finds and declares that it is in the best interest of the state to regulate medical cannabis, adult-use cannabis, cannabinoid hemp and hemp extracts under independent entities, known as the cannabis control board and the office of cannabis management.

§ 3. Definitions. Whenever used in this chapter, unless otherwise expressly stated or unless the context or subject matter requires a different meaning, the following terms shall have the representative meanings hereinafter set forth or indicated:

1. "Applicant" unless otherwise specified in this chapter, shall mean a person applying for any cannabis, medical cannabis or cannabinoid hemp license or permit issued by the New York state cannabis control board pursuant to this chapter that: has a significant presence in New York state, either individually or by having a principal corporate location in the state; is incorporated or otherwise organized under the laws of this state; or a majority of the ownership are residents of this state. For the purposes of this subdivision, "person" means an individual, institution, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity.

2. "Cannabinoid" means the phytocannabinoids found in hemp and does not include synthetic cannabinoids as that term is defined in subdivision (g) of schedule I of section thirty-three hundred six of the public health law.

3. "Cannabinoid hemp" means any hemp and any product processed or derived from hemp, that is used for human consumption provided that when such product is packaged or offered for retail sale to a consumer, it shall not have a concentration of more than three tenths of a percent delta-9 tetrahydrocannabinol.

4. "Cannabinoid hemp processor license" means a license granted by the office to process, extract, pack or manufacture cannabinoid hemp or hemp extract into products, whether in intermediate or final form, used for human consumption.

5. "Cannabis" means all parts of the plant of the genus Cannabis, whether growing or not; the seeds thereof; the resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. It does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. It does not include hemp, cannabinoid hemp or hemp extract as defined by this section or any drug products approved by the federal Food and Drug Administration.

6. "Cannabis consumer" means a person twenty-one years of age or older acting in accordance with any provision of this chapter.

S. 854--A 4

7. "Cannabis control board" or "board" means the New York state cannabis control board created pursuant to article two of this chapter.

8. "Cannabis flower" means the flower of a plant of the genus Cannabis that has been harvested, dried, and cured, prior to any processing whereby the plant material is transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients. Cannabis flower excludes leaves and stem.

9. "Cannabis product" or "adult-use cannabis product" means cannabis, concentrated cannabis, and cannabis-infused products for use by a cannabis consumer.

10. "Cannabis-infused products" means products that have been manufactured and contain either cannabis or concentrated cannabis and other ingredients that are intended for use or consumption.

11. "Cannabis trim" means all parts of the plant of the genus Cannabis other than cannabis flower that have been harvested, dried, and cured, but prior to any further processing.

12. "Caring for" means treating a patient, in the course of which the practitioner has completed a full assessment of the patient's medical history and current medical condition.

13. "Certification" means a certification made under this chapter.

14. "Certified medical use" includes the acquisition, cultivation, manufacture, delivery, harvest, possession, preparation, transfer, transportation, or use of medical cannabis for a certified patient, or the acquisition, administration, cultivation, manufacture, delivery, harvest, possession, preparation, transfer, or transportation of medical cannabis by a designated caregiver or designated caregiver facility, or paraphernalia relating to the administration of cannabis, including whole cannabis flower, to treat or alleviate a certified patient's medical condition or symptoms associated with the patient's medical condition.

15. "Certified patient" means a patient who is a resident of New York state or receiving care and treatment in New York state as determined by the board in regulation, and is certified under this chapter.

16. "Chief equity officer" means the chief equity officer of the office of cannabis management.

17. "Concentrated cannabis" means: (a) the separated resin, whether crude or purified, obtained from cannabis; or (b) a material, preparation, mixture, compound or other substance which contains more than three percent by weight or by volume of total THC, as defined in this section.

18. "Condition" means having one of the following conditions: cancer, positive status for human immunodeficiency virus or acquired immune deficiency syndrome, amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, inflammatory bowel disease, neuropathies, Huntington's disease, posttraumatic stress disorder, pain that degrades health and functional capability where the use of medical cannabis is an alternative to opioid use, substance use disorder, Alzheimer's, muscular dystrophy, dystonia, rheumatoid arthritis, autism or any other condition certified by the practitioner.

19. "Cultivation" means growing, cloning, harvesting, drying, curing, grading, and trimming of cannabis plants for sale to certain other categories of cannabis license- and permit-holders.

S. 854--A 5

20. "Delivery" means the direct delivery of cannabis products by a retail licensee, microbusiness licensee, or delivery licensee to a cannabis consumer.

21. "Designated caregiver facility" means a facility that registers with the office to assist one or more certified patients with the acquisition, possession, delivery, transportation or administration of medical cannabis and is a: general hospital or residential health care facility operating pursuant to article twenty-eight of the public health law; an adult care facility operating pursuant to title two of article seven of the social services law; a community mental health residence established pursuant to section 41.44 of the mental hygiene law; a hospital operating pursuant to section 7.17 of the mental hygiene law; a mental hygiene facility operating pursuant to article thirty-one of the mental hygiene law; an inpatient or residential treatment program certified pursuant to article thirty-two of the mental hygiene law; a residential facility for the care and treatment of persons with developmental disabilities operating pursuant to article sixteen of the mental hygiene law; a residential treatment facility for children and youth operating pursuant to article thirty-one of the mental hygiene law; a private or public school; research institution with an internal review board; or any other facility as determined by the board in regulation.

22. "Designated caregiver" means an individual designated by a certified patient in a registry application. A certified patient may designate up to five designated caregivers not counting designated caregiver facilities or designated caregiver facilities' employees.

23. "Designated caregiver facility employee" means an employee of a designated caregiver facility.

24. "Distributor" means any person who sells at wholesale any cannabis product, except medical cannabis, for the sale of which a license is required under the provisions of this chapter.

25. "Executive director" means the executive director of the office of cannabis management.

26. "Form of medical cannabis" means characteristics of the medical cannabis recommended or limited for a particular certified patient, including the method of consumption and any particular strain, variety, and quantity or percentage of cannabis or particular active ingredient, or whole cannabis flower.

27. "Hemp" means the plant Cannabis sativa L. and any part of such plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration (THC) of not more than three-tenths of a percent on a dry weight basis. It shall not include "medical cannabis" as defined in this section.

28. "Hemp extract" means all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers derived from hemp, used or intended for human consumption, for its cannabinoid content, with a delta-9 tetrahydrocannabinol concentration of not more than an amount determined by the office in regulation. For the purpose of this article, hemp extract excludes (a) any food, food ingredient or food additive that is generally recognized as safe pursuant to federal law; or (b) any hemp extract that is not used for human consumption. Such excluded substances shall not be regulated pursuant to the provisions of this article but are subject to other provisions of applicable state law, rules and regulations.

29. "Labor peace agreement" means an agreement between an entity and a labor organization that, at a minimum, protects the state's proprietary

S. 854--A 6

interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the entity.

30. "Laboratory testing facility" means any independent laboratory capable of testing cannabis and cannabis products for adult-use and medical-use; cannabinoid hemp and hemp extract; or for all categories of cannabis and cannabis products as per regulations set forth by the state cannabis control board.

31. "License" means a written authorization as provided under this chapter permitting persons to engage in a specified activity authorized pursuant to this chapter.

32. "Licensee" means an individual or an entity who has been granted a license under this chapter.

33. "Medical cannabis" means cannabis as defined in this section, intended for a certified medical use, as determined by the board in consultation with the commissioner of health.

34. "Microbusiness" means a licensee that may act as a cannabis producer for the cultivation of cannabis, a cannabis processor, a cannabis distributor and a cannabis retailer under this article; provided such licensee complies with all requirements imposed by this article on licensed producers, processors, distributors and retailers to the extent the licensee engages in such activities.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act in relation to constituting chapter 7-A of the consolidated laws, in relation to the creation of a new office of cannabis management, as an independent entity within the division of alcoholic beverage control, providing for the licensure of persons authorized to cultivate, process, distribute and sell cannabis and the use of cannabis by persons aged twenty-one or older; to amend the public health law, in relation to the description of cannabis; to amend the penal law, in relation to the growing and use of cannabis by persons twenty-one years of age or older; to amend the tax law, in relation to providing for the levying of taxes on cannabis; to amend the criminal procedure law, the civil practice law and rules, the general business law, the state finance law, the execu- tive law, the penal law, the alcoholic beverage control law, the general obligations law, the social services law, the labor law, the family court act, and the vehicle and traffic law, in relation to making conforming changes; to amend the public health law, in relation to the definition of smoking; to amend the state finance law, in relation to establishing the New York state cannabis revenue fund, the New York state drug treatment and public education fund and the New York state community grants reinvestment fund; to amend chapter 90 of the laws of 2014 amending the public health law, the tax law, the state finance law, the general business law, the penal law and the criminal procedure law relating to medical use of marihuana, in relation to the effectiveness thereof; to amend chapter 174 of the laws of 1968 constituting the urban development corporation act, in relation to loans to social and economic equity applicants, providing increased drug recognition awareness and Advanced Roadside Impaired Driver Enforcement training, directing a study designed to evaluate methodologies and technologies for the detection of cannabis-impaired driving, providing for the transfer of employees and functions from the department of health to the office of cannabis management; to repeal certain provisions of the public health law relating to growing of cannabis and medical use of marihuana; to repeal article 221 of the penal law relating to offenses involving mari- huana; to repeal paragraph (f) of subdivision 2 of section 850 of the general business law relating to drug related paraphernalia; and to repeal certain provisions of the penal law relating to making conforming changes

Purpose or general idea of bill

The purpose of this bill is to establish a new Office of Cannabis Management for the regulation of cannabis, to create a regulated and taxed cannabis industry in New York, and to provide for various social and economic justice initiatives related thereto.

Summary of provisions

Section 1 of the bill establishes the title.

Read the full memo (1,902 words)

Section 2 establishes a new Chapter 7-A of the consolidated laws enti- tled "Cannabis Law' as follows: Article 1 of the Cannabis Law provides legislative findings and intent and offers definitions of terms. Article 2 of the Cannabis Law establishes the Office of Cannabis Management; defines the powers of the cannabis control board, executive director,

chief equity officer, and state cannabis advisory board; and establishes rulemaking authority and procedures for the office.

Article 3 of the Cannabis Law provides for the regulation of medical cannabis by the Office of Cannabis Management.

Article 4 of the Cannabis Law provides for the regulation of adult-use cannabis by the Office of Cannabis Management.

Article 5 of the Cannabis Law provides for the regulation of cannabinoid hemp and hemp extract by the Office of Cannabis Management. Article 6 of the Cannabis Law establishes general provisions for the Cannabis Law.

Sections 3 through 62-h of the bill amend various sections of law to conform New York State law as it relates to the Cannabis Law and the purposes of this act, including to:

*remove marihuana from the schedule of controlled substances;

*provide for the lawful possession, use, and personal growth of canna- bis;

*expand sealing and expungement opportunities for past marijuana convictions;

*establish parameters related to cannabis and probation, parole, and Family Court matters;

*provide for the taxation of cannabis;

*provide for the distribution of tax revenues, including:

*40% to the community grants reinvestment fund;

*40% to education in order to add to the State's current investment in education;

*20% for mental health services; youth cannabis use prevention; public health campaigns; and drug treatment, prevention, and harm reduction services; and

*certain administrative costs to implement this act.

*provide for vehicle and traffic, and other public safety measures;

*clarify workplace standards and employee/employer rights and protections related to cannabis;

* research potential technologies to assist in detecting motorist canna- bis impairment; and

* transfer certain functions and employees from various state agencies to the Office of Cannabis Management.

Section 63 is the severability clause. Section 64 is the effective date.

Justification

New York's marihuana policies are broken, unjust, and outdated. The Marihuana Regulation and Taxation Act (MRTA) is based on the recognition that New York's existing marihuana policies have failed to protect the welfare of our communities. Marihuana prohibition has thrust thousands of New Yorkers into the criminal justice system for non-violent offenses, denying many the fundamental right to participate in the demo- cratic process of voting and inhibiting otherwise law-abiding citizens' ability to access housing, student loans, employment opportunities, and other vital services. Additionally, rather than curtailing youth-mari- huana usage, existing marihuana laws have led to an illicit market that has done little to address marihuana usage by minors.

Existing marihuana laws have led to costly overuse of law enforcement resources and in some instances discriminatory police practices that have perpetuated systematic racism and discrimination increasing the prison population with non-violent offenders. Over the past two decades, New York has become the marihuana arrest capital of the country, with nearly 800,000 marihuana arrests and summons. These arrests dispropor- tionately impact the lives of African-American and Latinx communities. Black and Brown New Yorkers are swept into the criminal justice system for marihuana use while white New Yorkers have generally been evaded prosecution While government studies show that whites of all ages use marihuana at the same rate as People of Color, a stark difference in arrest rates remains. Across New York City, African-Americans are arrested on low-level marihuana charges at eight times the rate of white, non-Hispanic people and Latinxs are arrested at five times the rate of whites. Thus, one of the largest drivers of racial disparity in criminalization and incarceration rates is the inequity of how the law is applied in marihuana arrests. The intent of this act is to regulate, control, and tax cannabis. The MRTA will generate millions of dollars in new revenue, prevent access to marihuana by those under the age of twen- ty-one, reduce the illegal drug market and violent crime, help transi- tion otherwise law-abiding citizens engaged in the Legacy market to the legal market, and create new industries and increase employment. With the enactment of the MRTA, the New York State Legislature has an oppor- tunity to end the racially disparate impact of existing marihuana poli- cies and their enforcement.

Sixty million Americans now live in states where adult-use cannabis is legal. Nationwide, public perception of cannabis is growing more favora- ble, with 61% of the population supporting legalization. In NYC fatal drug overdoses are now four times more common than homicides.

The New York Department of Health concluded that marihuana is a far safer pain reliever than opioids, and reduces the risk of fatal over- doses that are prevalent across the state and country. In states that have legalized cannabis, opioid overdose rates were 25% lower compared with states with no legal access to cannabis. Additionally, two-thirds of Americans also view cannabis as being safer than opioids in the management of pain. There are roughly 1.5 million regular cannabis users -in New York, half of whom live in New York City. In May of 2018, NYC Comptroller Stringer released a report which estimates a $3.1 billion adult-use cannabis market for New York State, with $1.1 billion just in New York City. With the enactment of the MRTA New York State could real- ize a projected $436 million in tax revenue, while New York City could accrue an additional $336 million in tax revenue. The need to repair the harms wrought on communities of color by the war on drugs requires a definitive framework, in statute, for reinvestment. This legislation directs 50% of the tax revenue to establish the Community Grants Rein- vestment Fund, aimed at giving back to the communities that have been the most disproportionately affected by current marihuana laws. States across the country that have recently legalized marihuana, from Massa- chusetts to Alaska, are reinvesting in programs that offer people a new start through community re-entry programs, schools, job development, drug treatment, and legal services. New York has the opportunity to become a leading example in sustainable reinvestment with this explicit- ly dedicated revenue percentage and type of fund.

Prior legislative history

2019-2020:S.1527C/A.1617C 2017-2018:S.3040C/A.3506C 2015-2016:S.1747/A.3089A 2013-2014:S.6005/A.8341

Fiscal implications for state and local governments

The increase of revenue for state and local governments will be deter- mined.

Effective date

This act shall take effect immediately; provided, however, that sections six and six-a of this act shall take effect six months after the full cannabis control board created by article two of the cannabis law has been appointed and provided that the governor shall notify the legisla- tive bill drafting commission upon such full appointment in order that the commission may maintain an accurate and timely effective data base of the official text of the laws of the state of New York in furtherance of effectuating the provisions of section 44 of the legislative law and section 70-b of the public officers law; provided, further that the expungement of marihuana convictions under section 160.50 of the crimi- nal procedure law, added by the amendment in section seventeen of this act, shall occur promptly and in any event no later than two years after the effective date of this act; the amendments to article 20-B of the tax law made by sections thirty-four, thirty-seven and thirty-eight of this act shall not affect the repeal of such article and shall be deemed repealed therewith; and provided, further, that sections thirty nine and forty of this act shall take effect April 1, 2022, and shall apply on and after such date to the sale or transfer of adult-use cannabis products to a retail dispensary; provided, further, that the amendments to article 179 of the penal law made by section forty-seven of this act shall not affect the repeal of such article and shall be deemed to be repealed therewith; provided, further, that the amendments to section 89-h of the state finance law made by section fifty of this act shall not affect the repeal of such section and shall be deemed repealed 03/27/21 255 65156-02-1 therewith; provided, further, that the amend- ments to subdivision 3 of section 853 of the general business law made by section fifty-six-a of this act shall not affect the repeal of such section and shall be deemed repealed therewith; and provided, further, that the amendments to subdivision 2 of section 3371 of the public health law made by section fifty-six-b of this act shall not affect the expiration of such subdivision and shall be deemed to expire therewith.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.